Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in adults with non-cirrhotic NASH and stage F2-F3 fibrosis
CTR20211818Phase 3Active
- Sponsor
- Novo Nordisk
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide, sponsored by Novo Nordisk. Started Aug 2021; status: active.
02
Drugs
Beyond the preview
Go deeper on CTR20211818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211818.